Early Stage Venture Unlearn.AI Raises Series A of $3000000

About Unlearn.AI

Unlearn.AI develops a platform to accelerate clinical trials for Alzheimer’s Disease, Multiple Sclerosis, and other complex diseases.

Website: Learn more on Unlearn.AI’s website

Crunchbase: Follow on Crunchbase

Series A – Unlearn.AI

Amount Raised3000000 USD
Announced Date2020-11-05
Equity Only FundingYes
Organization LocationSan Francisco, California, United States, North America
Funding StatusEarly Stage Venture
Number of Funding Rounds2
Lead Investors
Number of Investors3
Number of Partner Investors

Written by Startup News

Early Stage Venture Neurosensum Raises Series A of $600000

101 Best UK Startups Founded in 2020